# The risk of kidney transplant graft loss in sensitized vs. unsensitized patients is modified by prior transplant status

**Authors:** A. Nicholson, K. Tennankore, A. J. Vinson

PMC · DOI: 10.3389/frtra.2026.1712618 · Frontiers in Transplantation · 2026-02-16

## TL;DR

This study finds that patients who have had a prior kidney transplant and are highly sensitized face higher risks of graft loss and complications after a new transplant.

## Contribution

The study identifies that prior transplant status modifies the risk of adverse outcomes in sensitized kidney transplant recipients.

## Key findings

- Patients with a prior transplant and PRA >80% had a 1.56 times higher risk of death-censored graft loss.
- Prior transplant status significantly modified the association between PRA and graft loss outcomes.
- Sensitized patients with a prior transplant had higher risks of delayed graft function compared to those without a prior transplant.

## Abstract

A prior kidney transplant (KT) has been associated with an increased risk of graft loss following repeat transplantation. This study examined the risk of adverse posttransplant outcomes between patients with and without a prior transplant, depending on sensitization status.

We used propensity score matching to examine the combined exposure of sensitization status [panel-reactive antibody (PRA) 0%, >0%–80%, and >80%] and first/repeat KT as a nested variable in adults across the US [2000–2017; Scientific Registry of Transplant Recipients (SRTR)]. We then used multivariable Cox and logistic regression models to examine the association between the nested variable and death-censored graft loss (DCGL), all-cause graft loss (ACGL), and delayed graft function (DGF). Effect modification between PRA status (20%) and prior KT status was assessed for each outcome.

Among 38,660 matched patients, DCGL (adjusted Hazard Ratio (aHR) 1.56, 95% CI 1.47–1.66), ACGL (aHR 1.42, 95% CI 1.35–1.49), and DGF (adjusted Odds Ratio (aOR) 1.89, 95% CI 1.75–2.03) risk was highest with a prior KT and PRA >80% (vs. unsensitized transplant-naïve patients). The risk associated with increased PRA was greater in those with a prior transplant. Prior KT modified the association between increased PRA and DCGL, ACGL, and DGF (p-value < 0.001).

Prior KT status modified the association between PRA and adverse outcomes. Sensitized patients (PRA >80%) with a prior KT faced higher risks of DCGL, ACGL, and DGF compared with sensitized patients without a prior KT.

## Full-text entities

- **Genes:** S100A6 (S100 calcium binding protein A6) [NCBI Gene 6277] {aka 2A9, 5B10, CABP, CACY, PRA, S10A6}, HLA-A (major histocompatibility complex, class I, A) [NCBI Gene 3105] {aka HLAA}, AGTR1 (angiotensin II receptor type 1) [NCBI Gene 185] {aka AG2S, AGTR1B, AT1, AT1AR, AT1B, AT1BR}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}
- **Diseases:** polycystic kidney disease (MESH:D007690), kidney disease (MESH:D007674), AMR (MESH:C565965), coronary artery disease (MESH:D003324), ESKD (MESH:D007676), diabetes (MESH:D003920), loss (MESH:D016388), peripheral vascular disease (MESH:D016491), glomerulonephritis (MESH:D005921), DGF (MESH:D051799), DCGL (MESH:D003643), ACGL (MESH:D055589), hypertension (MESH:D006973)
- **Chemicals:** steroid (MESH:D013256)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950723/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950723/full.md

## References

38 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950723/full.md

---
Source: https://tomesphere.com/paper/PMC12950723